Carsten Ehrhardt
Impact in
- Pharmaceutical Science top 0.5%
- Advanced Drug Delivery Systems
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Inhalation and Respiratory Drug Delivery 47
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 6
- Oncology 33
- Drug Transport and Resistance Mechanisms 33
- Co-authors
- Udo Bakowsky (17 shared papers)Claus‐Michael Lehr (27 shared papers)Stephen Timothy Buckley (13 shared papers)Anne Marie Healy (13 shared papers)Kwang‐Jin Kim (16 shared papers)Ben Forbes (7 shared papers)Carsten Kneuer (7 shared papers)Alexander N. Zelikin (1 shared paper)
- Journals
- European Journal of Pharmaceutical Sciences (11 papers)European Journal of Pharmaceutics and Biopharmaceutics (10 papers)The FASEB Journal (9 papers)Pharmaceutical Research (9 papers)Molecular Pharmaceutics (7 papers)
- Partner nations
- IrelandGermanyUnited States
In The Last Decade
Carsten Ehrhardt
133 papers receiving 5.6k citations
Peers
Comparison fields: 5 of 123
- Pharmaceutical Science 576
- Biomaterials 904
- Pulmonary and Respiratory Medicine 2.2k
- Drug Discovery 20
- Clinical Biochemistry 262
Countries citing papers authored by Carsten Ehrhardt
This map shows the geographic impact of Carsten Ehrhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carsten Ehrhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carsten Ehrhardt more than expected).
Fields of papers citing papers by Carsten Ehrhardt
This network shows the impact of papers produced by Carsten Ehrhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carsten Ehrhardt. The network helps show where Carsten Ehrhardt may publish in the future.
Co-authors
The 25 scholars most cited alongside Carsten Ehrhardt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 133 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 316 | |
| 2 | 2016 | 288 | |
| 3 | 2005 | 260 | |
| 4 | 2005 | 218 | |
| 5 | 2010 | 217 | |
| 6 | 2010 | 211 | |
| 7 | 2009 | 161 | |
| 8 | 2014 | 123 | |
| 9 | 2012 | 121 | |
| 10 | 2006 | 116 | |
| 11 | 2003 | 114 | |
| 12 | 2003 | 111 | |
| 13 | 2002 | 110 | |
| 14 | 2005 | 108 | |
| 15 | 2009 | 106 | |
| 16 | 2008 | 101 | |
| 17 | 2005 | 96 | |
| 18 | 2009 | 91 | |
| 19 | 2019 | 88 | |
| 20 | 2002 | 85 |
About Carsten Ehrhardt
Carsten Ehrhardt is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Pharmaceutical Science, Biomaterials and Neurology, having authored 133 papers that have together received 5.8k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (47 papers), Drug Transport and Resistance Mechanisms (33 papers), Nanoparticle-Based Drug Delivery (11 papers), Advanced Drug Delivery Systems (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (6 papers), Barrier Structure and Function Studies (5 papers), Drug Solubulity and Delivery Systems (4 papers) and Mast cells and histamine (4 papers). The work is most often cited by research in Pharmaceutical Science (576 citations), Biomaterials (904 citations), Pulmonary and Respiratory Medicine (2.2k citations), Drug Discovery (20 citations) and Clinical Biochemistry (262 citations). Carsten Ehrhardt has collaborated with scholars based in Ireland, Germany and United States. Frequent co-authors include Udo Bakowsky, Claus‐Michael Lehr, Stephen Timothy Buckley, Anne Marie Healy, Kwang‐Jin Kim, Ben Forbes, Carsten Kneuer, Alexander N. Zelikin, Johanna J. Salomon and Michael M. Laue. Their work appears in journals such as European Journal of Pharmaceutical Sciences, European Journal of Pharmaceutics and Biopharmaceutics, The FASEB Journal, Pharmaceutical Research and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.